Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 3,810,241 | 2,458,779 | 1,415,921 | 1,176,283 | 308,874 |
| Cost of Goods | 594,089 | 379,920 | 286,475 | 164,906 | 70,657 |
| Gross Profit | 3,216,152 | 2,078,859 | 1,129,446 | 1,011,377 | 238,217 |
| Operating Expenses | 3,784,440 | 3,287,515 | 2,919,586 | 2,451,018 | 1,896,556 |
| Operating Income | -568,199 | -1,207,736 | -1,789,665 | -1,438,735 | -1,657,682 |
| Interest Expense | 0 | 0 | 0 | 0 | -1,998 |
| Other Income | 35,198 | 381,900 | -171,372 | 147 | 37,490 |
| Pre-tax Income | -533,001 | -825,836 | -1,961,037 | -1,438,588 | -1,618,194 |
| Income Tax | 111,785 | 55,872 | 42,778 | 19,228 | -17,671 |
| Net Income Continuous | -644,786 | -881,708 | -2,003,815 | -1,457,816 | -1,600,523 |
| Minority Interests | N/A | N/A | N/A | N/A | -3,617 |
| Net Income | $-644,786 | $-881,708 | $-2,003,815 | $-1,457,816 | $-1,596,906 |
| EPS Basic Total Ops | -6.12 | -8.45 | -19.43 | -15.71 | -19.13 |
| EPS Basic Continuous Ops | -6.12 | -8.45 | -19.43 | -15.71 | -19.17 |
| EPS Diluted Total Ops | -6.12 | -8.45 | -19.43 | -15.71 | -19.13 |
| EPS Diluted Continuous Ops | -6.12 | -8.45 | -19.43 | -15.71 | -19.17 |
| EPS Diluted Before Non-Recurring Items | -6.12 | -8.45 | -19.43 | -15.23 | -19.13 |
| EBITDA(a) | $-396,437 | $-1,120,061 | $-1,723,387 | $-1,392,278 | $-1,625,893 |